VasopressinInjection, USP
- Vial closure is not made with natural rubber latex
- Formulated, filled, and finished in our US-based manufacturing facilities
Pack NDC# | Strength | Supplied As | Shelf Pack | Vial Opening Size | Product Info | Availability | ||
---|---|---|---|---|---|---|---|---|
Strength:
20 Units/mL Supplied As:1 mL |
0517-1020-25 |
20 Units/mL |
1 mL |
25 | 13 mm | Product Label Full Prescribing Information Safety Data Sheet | Limited Availability | |
Product Label Full Prescribing Information Safety Data Sheet Contains 5 mg/mL chlorobutanol as a preservative Wholesaler Numbers
Case Information
|
Contact Us
-
P: 800-645-1706
(8:00am–6pm Monday - Thursday and Friday 8:00am–4pm Eastern Time) -
P: 800-734-9236
F: 610-650-0170E: pv@americanregent.comAdverse Drug Events (ADEs) may be reported to the FDA:
Phone: 1-800-FDA-1088
Web: www.fda.gov/medwatchP: 888-354-4859
E: pqc@americanregent.comP: 888-354-4855
(9am–5pm Eastern Time, Monday - Friday)E: ma@americanregent.comFor drug information outside of normal business hours that cannot wait until the next day, please call:
P: 877-845-6371
American Regent, Inc.
5 Ramsey Road
Shirley, NY 11967P: 631-924-4000
F: 631-924-1731By clicking Submit, you confirm that you accept our Privacy Policy and that you agree to your personal contact information being used to contact you and added to our database. If at any time you wish your personal information to be removed from the American Regent® database, please submit a message request to corpcommunications@americanregent.com.
Vasopressin Injection, USP
For intravenous use. Dilute prior to administration.
INDICATIONS AND USAGE
Vasopressin injection is indicated to increase blood pressure in adults with vasodilatory shock who remain hypotensive despite fluids and catecholamines.IMPORTANT SAFETY INFORMATION
CONTRAINDICATIONS
Vasopressin injection is contraindicated in patients with known allergy or hypersensitivity to 8-L-arginine vasopressin or chlorobutanol.WARNINGS AND PRECAUTIONS
Can worsen cardiac function.
Patients may experience reversible diabetes insipidus.ADVERSE REACTIONS
The most common adverse reactions included decreased cardiac output, bradycardia, tachyarrhythmias, hyponatremia, and ischemia (coronary, mesenteric, skin, digital).The following additional adverse reactions were identified:
Bleeding/lymphatic system disorders: Hemorrhagic shock, decreased platelets, intractable bleeding
Cardiac disorders: Right heart failure, atrial fibrillation, bradycardia, myocardial ischemia
Hepatobiliary: Increased bilirubin levels
Renal/urinary disorders: Acute renal insufficiency
Vascular disorders: Distal limb ischemia
DRUG INTERACTIONS
Hemodynamic monitoring is recommended; adjust the dose of vasopressin as needed.USE IN SPECIFIC POPULATIONS
Pregnancy: May induce tonic uterine contractions.Pediatric Use: Safety and effectiveness have not been established.
Geriatric Use: Dose selection for an elderly patient should be cautious.
For additional safety information, please see Full Prescribing Information.
You are encouraged to report adverse drug events to American Regent, Inc. at 1-800-734-9236 or to the FDA by visiting www.fda.gov/medwatch or calling 1-800-FDA-1088.